Compare Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) vs EHang Holdings Ltd - ADR (EH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio-Rad Laboratories, Inc. Class A Common Stock vs EHang Holdings Ltd - ADR — how do they compare? Bio-Rad Laboratories, Inc. Class A Common Stock trades at $300.83 (market cap $8.04B), while EHang Holdings Ltd - ADR trades at $5.47 (market cap $413.36M). The key difference: Bio-Rad Laboratories, Inc. Class A Common Stock is far larger — about 19.5× EHang Holdings Ltd - ADR's market cap, and Bio-Rad Laboratories, Inc. Class A Common Stock is trading nearer its 52-week high, EHang Holdings Ltd - ADR nearer its low. Which is the better fit depends on your goals.
| BIO | EH | |
|---|---|---|
Market Cap | $8.04B | $413.36M |
Sector | Health | Industrials |
52-Week High | $339.75 | $19.99 |
52-Week Low | $241.71 | $5.41 |
Enterprise Value | $7.85B | $353.02M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BIO trades at $297.58, up 0.5% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $305. The stock shows strong profitability with a 51.87% gross margin and positive net income of $760M in 2025, though recent quarters have seen EPS misses. Cash flow from operations remains robust at $532M, supporting financial stability.
Outlook is cautiously optimistic with analyst support, but risks include earnings volatility and high P/E valuation. The company's return to profitability and solid balance sheet provide a foundation for growth, though investors should monitor execution against future earnings expectations and competitive pressures in the biotech sector.
EHang Holdings (EH) trades at $5.41, down 3.22% on the day, reflecting ongoing volatility in the advanced air mobility sector. The stock shows a bearish technical trend with oversold RSI signals, while fundamentals reveal persistent losses with a net margin of -77.56% in 2025 despite a gross margin of 61.53%. Recent Q1 2026 earnings beat expectations but highlighted a sharp quarterly revenue drop, underscoring execution challenges amid expansion efforts.
The outlook remains high-risk with mixed analyst sentiment; a $6.97 consensus target suggests modest upside, but deep losses and cash burn necessitate careful monitoring of commercialization progress. Key risks include operational scalability, regulatory hurdles, and intense competition in the emerging eVTOL market.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Bio-Rad Laboratories, Inc. Class A Common Stock
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Read more on BIO →About EHang Holdings Ltd - ADR
EHang Holdings Ltd is an autonomous aerial vehicle (AAV) technology platform company. It focuses on making safe, autonomous and eco-friendly air mobility accessible to everyone. EHang provides customers in various industries with AAV products and commercial solutions: air mobility (including passenger transportation and logistics), smart city management and aerial media solutions. As the forerunner of cutting-edge AAV technologies and commercial solutions in the global Urban Air Mobility industry, it continues to explore the boundaries of the sky to make flying technologies benefit life in smart cities.
Read more on EH →
